|
Global Schizophrenia Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
300 |
Global |
$2,995.00 |
|
|
Global Acne Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Orphan Diseases Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
250 |
Global |
$2,995.00 |
|
|
Global Hepatitis Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Melanoma Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global E-Coli Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Atherosclerosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Idiopathic Pulmonary Fibrosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Chronic Kidney Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Retinopathy Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
200 |
Global |
$2,995.00 |
|
|
Global Oral Health Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
1000 |
Global |
$2,995.00 |
|
|
Global MRSA Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Lung Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Respiratory Syncytial Virus Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Congestive Heart Failure Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Asthma Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Autoimmune Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|
|
Global Cystic Fibrosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Gastric Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Age-related Macular Degeneration Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Neuropathy Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Viral Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Allergy Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Leukemia Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Hypertension Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Smoking Cessation Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
